top of page

References

Medical Device

 

PediStick is classed as a Class I medical device

​

Keeping you safe, PediStick is protected with the following:

  1. ISO 13485

  2. UKCA & CE markings

  3. Registration under MHRA

 

​

References

​

  1. Bristow IR. Urea - the gold standard for emollients? Podiatry Now. 2016;19(10):20-3.
     

  2. Augustin M, Kirsten N, Körber A, Wilsmann-Theis D, Itschert G, Staubach-Renz P, et al. Prevalence, predictors and comorbidity of dry skin in the general population. 2019. J Eur Acad Dermatol Venereol.
     

  3. Bristow, I. R. (2012). "Emollients and the foot." Podiatry Now: S1-S8.
     

  4. Diabetes UK. Position statements reports: statistics. Available at: https://www.diabetes.org.uk/professionals/position-statements-reports/statistics
     

  5. Diabetes UK. Complications: Feet. Available at: https://www.diabetes.org.uk/guide-to-diabetes/complications/feet
     

  6. Hamatani M, Mori T, Oe M, Noguchi H, Takehara K, Amemiya A, Ohashi Y, Ueki K, Kadowaki T, Sanada H. Factors Associated With Callus in Patients with Diabetes, Focused on Plantar Shear Stress During Gait. J Diabetes Sci Technol. 2016 Nov 1;10(6):1353-1359.

  7. Bowen G, Bristow I, Chadwick P et al (2021) Optimal emollient treatment and prevention of diabetic foot complications. The Diabetic Foot Journal 24(1): 40–5.
     

  8. National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summary. Peripheral arterial disease: How common is it? Available at: https://cks.nice.org.uk/topics/peripheral-arterial-disease/background-information/prevalence/
     

  9. North West Podiatry Services Clinical Effectiveness Group – Rheumatology. Guidelines for the Management of Foot Health in Rheumatoid Arthritis. Version 2. Available at: https://usir.salford.ac.uk/id/eprint/11321/6/North_West_Clinical_Effectiveness_Group_-_guidelines_for_the_management_of_the_RA_foot_2010.pdf
     

  10. National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summary. Psoriasis: emollients. Available at: https://cks.nice.org.uk/topics/psoriasis/prescribing-information/emollients/
     

  11. National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summary. Eczema: emollients. Available at: https://cks.nice.org.uk/topics/eczema-atopic/prescribing-information/emollients/
     

  12.  Safer JD. Thyroid hormone action on skin. Dermatoendocrinol. 2011 Jul;3(3):211-5.
     

  13. Bensadoun RJ, Humbert P, Krutman J, Luger T, Triller R, Rougier A, et al. Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel. Cancer Manag Res. 2013;5:401–8. – cancer/chemo
     

  14. Niculet E, Bobeica C, Tatu AL. Glucocorticoid-Induced Skin Atrophy: The Old and the New. Clin Cosmet Investig Dermatol. 2020 Dec 30;13:1041-1050. 
     

  15. Yu D, Peat G, Bedson J, Jordan KP. Annual consultation incidence of osteoarthritis estimated from population-based health care data in England. Rheumatology (Oxford). 2015 Nov;54(11):2051-60.
     

  16. Versus Arthritis. The State of Musculoskeletal Health 2021. Available at: www.versusarthritis.org/media/24653/state-of-msk-health2-2021.pdf

​

​

​

bottom of page